Abstract
The strong link between inflammation and colorectal carcinogenesis provides the rationale for using anti-inflammatory agents for chemoprevention of colorectal cancer (CRC). Several naturally occurring substances with anti-inflammatory properties, used in a purified ‘nutraceutical’ form, including omega-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and polyphenols such as curcumin and resveratrol, have been demonstrated to have anti-CRC activity in preclinical models. As expected, these agents have an excellent safety and tolerability profile in Phase II clinical trials. Phase III randomized clinical trials of these naturally occurring substances are now beginning to be reported. The omega-3 polyunsaturated fatty acid EPA, in the free fatty acid (FFA) form, has been demonstrated to reduce adenomatous polyp number and size in patients with familial adenomatous polyposis (FAP), a finding which has prompted evaluation of this formulation of EPA for prevention of ‘sporadic’ colorectal neoplasia. Anti-inflammatory ‘nutraceuticals’ require further clinical evaluation in polyp prevention trials as they exhibit many of the characteristics of the ideal cancer chemoprevention agent, including safety, tolerability and patient acceptability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aggarwal BB, Sundaram C, Malani N et al (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1–75
Akedo I, Ishikawa H, Nakamura T et al (1998) Three cases with familial adenomatous polyposis diagnosed as having malignant lesions in the course of a long-term trial using docosahexaenoic acid (DHA)-concentrated fish oil capsules. Jpn J Clin Oncol 28:762–765
Balkwill F, Mantovani A (2010) Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther 87:401–406
Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NFκB as the matchmaker. Nature Immunol 12:715–723
Bhangle S, Kolasinski SL (2011) Fish oil in rheumatic diseases. Rheum Dis Clin North Am 37:77–84
Billerey-Larmonier C, Uno JK, Larmonier N et al (2008) Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 14:780–793
Calviello G, Serini S, Piccioni E (2007) n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 14:3059–3069
Carroll RE, Benya RV, Turgeon DK et al (2011) Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res 4:354–364
Chapkin RS, McMurray DN, Lupton JR (2007) Colon cancer, fatty acids and anti-inflammatory compounds. Curr Opin Gastroenterol 23:48–54
Chow HH, Hakim IA (2011) Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol Res 64:105–112
Churchill M, Chadburn A, Bilinski RT et al (2000) Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89:166–175
Cockbain AJ, Toogood GJ, Hull MA (2011) Omega-3 polyunsaturated fatty acids for the prevention and treatment of colorectal cancer. Gut. doi:10.1136/gut.2010.233718
Cruz-Correa M, Shoskes DA, Sanchez P (2006) Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4:1035–1038
Cui X, Jin Y, Hofseth AB et al (2010) Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res 3:549–559
De Caterina R (2011) n-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450
Dhillon N, Aggarwal BB, Newman RA et al (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14:4491–4499
Fichera A, Little N, Dougherty U et al (2007) A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 142:239–245
Fini L, Piazzi G, Ceccarelli C et al (2010) Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in ApcMin/+ mice. Clin Cancer Res 16:5703–5711
Fini L, Piazzi G, Daoud Y et al (2011) Chemoprevention of intestinal polyps in ApcMin/+ mice fed with western or balanced diets by drinking annurca apple polyphenol extract. Cancer Prev Res 4:907–915
Garcea G, Berry DP, Jones DJ et al (2005) Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14:120–125
Hanai H, Sugimoto K (2009) Curcumin has bright prospects for the treatment of inflammatory bowel disease. Curr Pharm Des 15:2087–2094
Huang M-T, Lou Y-R, Ma W et al (1994) Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54:5841–5847
Huerta S, Irwin RW, Heber D et al (2002) 1α, 25-(OH)2-D3 and its synthetic analogue decrease tumour load in the ApcMin mouse. Cancer Res 62:741–746
Irving GR, Karmokar A, Berry DP et al (2011) Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract Res Clin Gastroenterol 25:519−534
Kalra EK (2003) Nutraceutical––definition and introduction. AAPS J 5:25
Klampfer L (2011) Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 11:451–464
Krishnan AV, Feldman D (2011) Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol 51:311–336
MacLean CH, Newberry SJ, Mojica WA et al (2006) Effects of omega-3 fatty acids on cancer risk. A systematic review. J Am Med Assoc 295:403–415
Oh DY, Talukdar S, Bae EJ et al (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687–698
Patel VB, Misra S, Patel BB et al (2010) Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutr Cancer 62:958–967
Pereira MA, Grubbs CJ, Barnes LH et al (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17:1305–1311
Perkins S, Verschoyle RD, Hill K et al (2002) Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11:535–540
Ponnurangam S, Mondalek FG, Govind J et al (2010) Urine and serum analysis of consumed curcuminoids using an IkappaB-luciferase surrogate marker assay. In vivo 24:861–864
Popovinova BK, Kostadinova FI, Furuichi K et al (2009) Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis. Cancer Res 69:7884–7892
Rao CV, Rivenson A, Simi B, Reddy BS (1995) Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res 55:259–266
Ricciardiello L, Bazzoli F, Fogliano V (2011) Phytochemicals and colorectal cancer prevention-myth or reality? Nature Rev Gastroenterol Hepatol 8:592–596
Sanchez-Fidalgo S, Cardeno A, Villegas I et al (2010) Dietary supplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol 633:78–84
Sanders LM, Henderson CE, Hong MY et al (2004) An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocyte apoptosis. J Nutr 134:3233–3238
Schley PD, Brindley DN, Field CJ (2007) n-3 PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 137:548–553
Schneider Y, Duranton B, Gosse F et al (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39:102–107
Serhan CN, Chiang N, van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361
Shimizu M, Fukutomi Y, Ninomiya M et al (2008) Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev 17:3020–3025
Smith WL (2005) Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 17:174–182
Steinbach G, Lynch PM, Phillips RKS et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952
Sugimoto K, Hanai H, Tozawa K et al (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123:1912–1922
Tessitore L, Davit A, Sarotto I et al (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21:1619–1622
Touvier M, Chan DS, Lau R et al (2011) Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor poymorphisms and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 20:1003–1016
Ullman TA, Itzkowitz SH (2011) Intestinal inflammation and cancer. Gastroenterology 140:1807–1816
Vanamala J, Glagolenko A, Yang P et al (2008) Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARδ/PGE2 and elevation of PGE3. Carcinogenesis 29:790–796
Vecchio AJ, Simmons DM, Malkowski MG (2010) Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem 285:22152–22163
Vlachojannis J, Magora F, Chrubasik S (2011) Willow species and aspirin: different mechanisms of action. Phytother Res. doi:10.1002/ptr.3386
Wall R, Ross RP, Fitzgerald GF, Stanton C (2010) Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 68:280–289
Wang D, DuBois RN (2010) The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29:781–788
Weber WM, Hunsaker LA, Abcouwer SF et al (2005) Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem 13:3811–3820
West NJ, Belluzzi A, Lund EK et al (2009) Eicosapentaenoic acid (EPA), as the free fatty acid, reduces colonic crypt cell proliferation in patients with sporadic colorectal polyps. Gut 58(Suppl. 2):A68 (abstract)
West NJ, Clark SK, Philips RK et al (2010) Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut 59:918–925
World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC
World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update project interim report summary. Food, nutrition, physical activity, and the prevention of colorectal cancer
Zhang X, Giovannucci E (2011) Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract Res Clin Gastroenterol 25:485−494
Acknowledgments
Work in the Hull laboratory is funded by the National Institute for Health Research Efficacy & Mechanism Evaluation Programme, Yorkshire Cancer Research and an unrestricted Scientific Grant from SLA Pharma (UK).
Conflict of Interest Statement
Mark Hull has received an unrestricted Scientific Grant and a travel grant for conference travel from SLA Pharma (UK), which produces the ω-3 PUFA EPA, in the free fatty acid form.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hull, M.A. (2013). Nutritional Agents with Anti-lnflammatory Properties in Chemoprevention of Colorectal Neoplasia. In: Chan, A., Detering, E. (eds) Prospects for Chemoprevention of Colorectal Neoplasia. Recent Results in Cancer Research, vol 191. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30331-9_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-30331-9_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30330-2
Online ISBN: 978-3-642-30331-9
eBook Packages: MedicineMedicine (R0)